BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 26162684)

  • 1. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Z Rheumatol; 2017 Dec; 76(10):904-912. PubMed ID: 27638015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis.
    Song GG; Lee YH
    Int J Clin Pharmacol Ther; 2020 Oct; 58(10):550-556. PubMed ID: 32691727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis.
    Lee YH; Song GG
    Pharmacology; 2022; 107(9-10):439-445. PubMed ID: 35609529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis.
    Bae SC; Lee YH
    Z Rheumatol; 2019 Jun; 78(5):467-473. PubMed ID: 30039177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis.
    Lee YH; Song GG
    Z Rheumatol; 2023 Sep; 82(7):580-586. PubMed ID: 34545430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
    Jiang N; Jin S; Yu C; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Front Immunol; 2023; 14():1232244. PubMed ID: 37901212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2022 Oct; 31(12):1468-1476. PubMed ID: 35986446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis.
    Li K; Yu Y; Gao Y; Zhao F; Liang Z; Gao J
    Front Immunol; 2022; 13():859380. PubMed ID: 35444666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
    Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
    Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
    Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
    J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
    BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis.
    Lee YH; Song GG
    Z Rheumatol; 2024 Feb; 83(Suppl 1):140-147. PubMed ID: 37278824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of rituximab, mycophenolate, and cyclophosphamide in active antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Int J Clin Pharmacol Ther; 2021 Oct; 59(10):645-653. PubMed ID: 34338191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N; McEvoy M; Attia J; Ingsathit A; Ngamjanyaporn P; Thakkinstian A
    Medicine (Baltimore); 2010 Jul; 89(4):227-235. PubMed ID: 20616662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.